Symbol="PTGX"
AssetType="Common Stock"
Name="Protagonist Therapeutics Inc"
Description="Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California."
CIK="1377121"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1166137000"
EBITDA="-146183008"
PERatio="None"
PEGRatio="0"
BookValue="5.12"
DividendPerShare="0"
DividendYield="0"
EPS="-2.78"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.292"
ReturnOnEquityTTM="-0.49"
RevenueTTM="0"
GrossProfitTTM="26581000"
DilutedEPSTTM="-2.78"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="39.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="13.27"
PriceToBookRatio="1.925"
EVToRevenue="5.84"
EVToEBITDA="-1.604"
Beta="1.887"
num_52WeekHigh="30.1"
num_52WeekLow="7.24"
num_50DayMovingAverage="22.29"
num_200DayMovingAverage="18.28"
SharesOutstanding="57530000"
DividendDate="None"
ExDividendDate="None"
symbol="PTGX"
open="20.20"
high="20.58"
low="20.06"
price="20.37"
volume="498159.00"
latest_trading_day="2023-08-23"
previous_close="20.19"
change="0.18"
change_percent="0.8915%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="37"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="63"
Volume_recent_avg="1088471"
Change_recent_avg="-0.04"
Delta_recent_avg="1.19"
Variance_recent_avg="0.6"
Change_ratio_recent_avg="-0.22"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="63"
Aroon_momentum_negative="37"
image_negative_thumbnail_id_1="1142"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0175.jpeg"
image_negative_thumbnail_id_2="1157"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0191.jpeg"
image_neutral_thumbnail_id_1="566"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_neutral_thumbnail_id_2="537"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0062.jpeg"
image_positive_thumbnail_id_1="617"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0091.jpeg"
image_positive_thumbnail_id_2="1014"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0176.jpeg"
image_professor_thumbnail_id_1="1167"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
